# An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

> **NCT05626387** · PHASE4 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 144 (estimated)

## Conditions studied

- Hypersensitivity Pneumonitis

## Interventions

- **DRUG:** Mycophenolate Mofetil plus prednisolone
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT05626387
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-23
- **Primary completion:** 2025-09-23
- **Final completion:** 2025-10-23
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626387, "An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05626387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*